United States · FDA National Drug Code directory
ambrisentan
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 47335-236_294580cb-5622-4f48-89a8-99000a7a2964
- Product NDC
- 47335-236
- Form
- TABLET, FILM COATED
- Composition / generic term
- ambrisentan
- Labeler
- Sun Pharmaceutical Industries, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20190429
- Source listing expiry
- 20261231
Source-listed ingredients
- AMBRISENTAN — 5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 3 BLISTER PACK in 1 CARTON (47335-236-64) / 10 TABLET, FILM COATED in 1 BLISTER PACK (47335-236-60) · 47335-236-64
- 1 BLISTER PACK in 1 CARTON (47335-236-66) / 10 TABLET, FILM COATED in 1 BLISTER PACK (47335-236-60) · 47335-236-66
- 30 TABLET, FILM COATED in 1 BOTTLE (47335-236-83) · 47335-236-83
- 10 TABLET, FILM COATED in 1 BOTTLE (47335-236-85) · 47335-236-85
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →